13

Nov

2023

APCI and Transparency-Rx Unite in Congressional Advocacy for Critical PBM Reforms

Organizations to Underscore Need for Legislation that De-links Major PBM Profits from Drug Prices

18

Sep

2023

APCI Urges Federal Agencies to Halt Further Integration of Insurers, PBMs

Comments call for DOJ, FTC investigation of PBM, insurer practices

24

May

2023

APCI Calls on Major Institutional Investor to Demand PBM Changes

In a letter sent to one of the largest investors in America’s Big Three PBMs, APCI urged Vanguard, Inc., to use its influence to curb abusive PBM practices that increase prescription drug prices for patients.

1234 Last